Treatment of central nervous system damage
The invention provides a method of promoting neuronal plasticity in the CNS of a mammal, the method comprising administering to the CNS of the mammal an agent that reduces the inhibitory properties of chondroitin sulphate proteoglycans. Preferred agents are chondroitinases and sulfatases, e.g. chondroitinase ABC. Also provided are methods of identifying further agents.
Patents:AU 2,009,200,025
Inventor(s):
BRADBURY ELIZABETH JANE; MCMAHON STEPHEN BRENDAN; FAWCETT JAMES
Type of Offer:
Sale
« More Medical Patents